US Stock MarketDetailed Quotes

CADL Candel Therapeutics

Watchlist
  • 5.570
  • -0.080-1.42%
Close Apr 1 16:00 ET
  • 5.570
  • 0.0000.00%
Post 20:01 ET
263.10MMarket Cap-3.20P/E (TTM)

Candel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
189.88%102.65M
189.88%102.65M
-61.48%16.56M
-58.66%21.45M
-56.61%25.71M
-49.45%35.41M
-49.45%35.41M
-44.31%42.98M
-40.20%51.89M
-37.17%59.26M
-Cash and cash equivalents
189.88%102.65M
189.88%102.65M
-61.48%16.56M
-58.66%21.45M
-56.61%25.71M
-49.45%35.41M
-49.45%35.41M
-44.31%42.98M
-40.20%51.89M
-37.17%59.26M
Other current assets
-16.91%1.15M
-16.91%1.15M
-27.90%1.53M
-12.74%1.28M
-45.62%1.42M
-26.66%1.38M
-26.66%1.38M
12.24%2.12M
169.85%1.47M
97.51%2.62M
Total current assets
182.10%103.8M
182.10%103.8M
-59.90%18.09M
-57.39%22.74M
-56.14%27.14M
-48.85%36.8M
-48.85%36.8M
-42.96%45.1M
-38.89%53.36M
-35.31%61.88M
Non current assets
Net PPE
-32.05%2.73M
-32.05%2.73M
-32.14%3.09M
-30.85%3.4M
-27.15%3.71M
-26.61%4.02M
-26.61%4.02M
-19.68%4.56M
-13.80%4.92M
-6.97%5.1M
-Gross PPE
-4.94%5.81M
-4.94%5.81M
-7.35%5.93M
-8.04%5.99M
-6.24%6.05M
-7.54%6.11M
-7.54%6.11M
-2.81%6.4M
1.61%6.52M
7.67%6.46M
-Accumulated depreciation
-47.25%-3.08M
-47.25%-3.08M
-54.02%-2.83M
-62.32%-2.59M
-72.19%-2.34M
-85.03%-2.09M
-85.03%-2.09M
-102.42%-1.84M
-126.56%-1.6M
-162.86%-1.36M
Other non current assets
-13.87%329K
-13.87%329K
-15.80%341K
-18.35%347K
38.35%368K
43.61%382K
43.61%382K
52.26%405K
59.77%425K
-39.13%266K
Total non current assets
-30.47%3.06M
-30.47%3.06M
-30.81%3.43M
-29.85%3.75M
-23.90%4.08M
-23.36%4.4M
-23.36%4.4M
-16.46%4.96M
-10.53%5.35M
-9.35%5.36M
Total assets
159.38%106.87M
159.38%106.87M
-57.02%21.52M
-54.89%26.49M
-53.57%31.22M
-46.97%41.2M
-46.97%41.2M
-41.11%50.06M
-37.08%58.71M
-33.80%67.24M
Liabilities
Current liabilities
Payables
-43.84%237K
-43.84%237K
18.40%296K
-9.79%433K
-20.27%472K
11.05%422K
11.05%422K
-74.23%250K
-69.70%480K
-57.29%592K
-accounts payable
-43.84%237K
-43.84%237K
18.40%296K
-9.79%433K
-20.27%472K
11.05%422K
11.05%422K
-74.23%250K
-69.70%480K
-57.29%592K
Current accrued expenses
17.38%5.11M
17.38%5.11M
33.25%4.57M
-8.01%3.22M
-3.31%2.77M
-7.77%4.36M
-7.77%4.36M
-22.86%3.43M
-7.81%3.5M
-19.53%2.87M
Current debt and capital lease obligation
11.22%10.46M
11.22%10.46M
57.62%10.4M
149.95%10.35M
495.32%10.29M
1,927.16%9.41M
1,927.16%9.41M
1,360.18%6.6M
840.91%4.14M
303.03%1.73M
-Current debt
11.27%9.9M
11.27%9.9M
61.49%9.85M
168.59%9.81M
679.49%9.77M
--8.89M
--8.89M
--6.1M
--3.65M
--1.25M
-Current capital lease obligation
10.33%566K
10.33%566K
10.40%552K
10.45%539K
10.50%526K
10.56%513K
10.56%513K
10.62%500K
10.91%488K
10.96%476K
Other current liabilities
--21.72M
--21.72M
----
----
----
----
----
54.84%48K
-23.81%48K
-48.94%48K
Current liabilities
164.59%37.53M
164.59%37.53M
47.85%15.27M
71.46%14M
158.54%13.54M
152.61%14.18M
152.61%14.18M
75.09%10.33M
38.87%8.16M
-4.31%5.24M
Non current liabilities
Long term debt and capital lease obligation
-77.46%3.01M
-77.46%3.01M
-65.25%5.62M
-55.94%8.21M
-48.76%10.79M
-40.20%13.36M
-40.20%13.36M
-27.67%16.17M
-16.62%18.64M
-5.83%21.06M
-Long term debt
-78.98%2.6M
-78.98%2.6M
-66.38%5.07M
-56.82%7.52M
-49.46%9.96M
-40.61%12.38M
-40.61%12.38M
-27.40%15.06M
-15.64%17.4M
-4.03%19.7M
-Long term capital lease obligation
-58.17%407K
-58.17%407K
-49.86%555K
-43.57%698K
-38.59%837K
-34.52%973K
-34.52%973K
-31.16%1.11M
-28.29%1.24M
-25.84%1.36M
Non current deferred liabilities
----
----
----
----
----
----
----
--108K
--120K
--132K
Derivative product liabilities
--0
--0
3,568.82%15.89M
1,305.13%14.25M
-21.50%909K
-51.33%916K
-51.33%916K
-90.64%433K
-79.70%1.01M
-88.38%1.16M
Total non current liabilities
-78.91%3.01M
-78.91%3.01M
28.69%21.51M
13.59%22.46M
-47.65%11.7M
-41.42%14.27M
-41.42%14.27M
-38.06%16.71M
-27.70%19.77M
-30.86%22.35M
Total liabilities
42.46%40.54M
42.46%40.54M
36.00%36.77M
30.50%36.46M
-8.51%25.24M
-5.07%28.46M
-5.07%28.46M
-17.76%27.04M
-15.93%27.94M
-27.02%27.59M
Shareholders'equity
Share capital
61.72%469K
61.72%469K
11.03%322K
4.48%303K
0.69%292K
0.00%290K
0.00%290K
0.00%290K
0.00%290K
1.05%290K
-common stock
61.72%469K
61.72%469K
11.03%322K
4.48%303K
0.69%292K
0.00%290K
0.00%290K
0.00%290K
0.00%290K
1.05%290K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-40.27%-192.21M
-40.27%-192.21M
-41.45%-178.13M
-42.54%-167.49M
-34.63%-145.25M
-38.29%-137.03M
-38.29%-137.03M
-33.96%-125.93M
-37.72%-117.5M
-32.91%-107.88M
Paid-in capital
72.42%258.51M
72.42%258.51M
9.31%163M
6.22%157.66M
2.50%151.38M
2.02%149.93M
2.02%149.93M
1.93%149.11M
1.98%148.43M
2.11%147.69M
Less: Treasury stock
0.00%448K
0.00%448K
0.00%448K
0.00%448K
0.00%448K
0.00%448K
0.00%448K
0.00%448K
0.00%448K
--448K
Total stockholders'equity
420.42%66.33M
420.42%66.33M
-166.27%-15.26M
-132.41%-9.97M
-84.92%5.98M
-73.29%12.75M
-73.29%12.75M
-55.83%23.02M
-48.78%30.77M
-37.81%39.65M
Total equity
420.42%66.33M
420.42%66.33M
-166.27%-15.26M
-132.41%-9.97M
-84.92%5.98M
-73.29%12.75M
-73.29%12.75M
-55.83%23.02M
-48.78%30.77M
-37.81%39.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 189.88%102.65M189.88%102.65M-61.48%16.56M-58.66%21.45M-56.61%25.71M-49.45%35.41M-49.45%35.41M-44.31%42.98M-40.20%51.89M-37.17%59.26M
-Cash and cash equivalents 189.88%102.65M189.88%102.65M-61.48%16.56M-58.66%21.45M-56.61%25.71M-49.45%35.41M-49.45%35.41M-44.31%42.98M-40.20%51.89M-37.17%59.26M
Other current assets -16.91%1.15M-16.91%1.15M-27.90%1.53M-12.74%1.28M-45.62%1.42M-26.66%1.38M-26.66%1.38M12.24%2.12M169.85%1.47M97.51%2.62M
Total current assets 182.10%103.8M182.10%103.8M-59.90%18.09M-57.39%22.74M-56.14%27.14M-48.85%36.8M-48.85%36.8M-42.96%45.1M-38.89%53.36M-35.31%61.88M
Non current assets
Net PPE -32.05%2.73M-32.05%2.73M-32.14%3.09M-30.85%3.4M-27.15%3.71M-26.61%4.02M-26.61%4.02M-19.68%4.56M-13.80%4.92M-6.97%5.1M
-Gross PPE -4.94%5.81M-4.94%5.81M-7.35%5.93M-8.04%5.99M-6.24%6.05M-7.54%6.11M-7.54%6.11M-2.81%6.4M1.61%6.52M7.67%6.46M
-Accumulated depreciation -47.25%-3.08M-47.25%-3.08M-54.02%-2.83M-62.32%-2.59M-72.19%-2.34M-85.03%-2.09M-85.03%-2.09M-102.42%-1.84M-126.56%-1.6M-162.86%-1.36M
Other non current assets -13.87%329K-13.87%329K-15.80%341K-18.35%347K38.35%368K43.61%382K43.61%382K52.26%405K59.77%425K-39.13%266K
Total non current assets -30.47%3.06M-30.47%3.06M-30.81%3.43M-29.85%3.75M-23.90%4.08M-23.36%4.4M-23.36%4.4M-16.46%4.96M-10.53%5.35M-9.35%5.36M
Total assets 159.38%106.87M159.38%106.87M-57.02%21.52M-54.89%26.49M-53.57%31.22M-46.97%41.2M-46.97%41.2M-41.11%50.06M-37.08%58.71M-33.80%67.24M
Liabilities
Current liabilities
Payables -43.84%237K-43.84%237K18.40%296K-9.79%433K-20.27%472K11.05%422K11.05%422K-74.23%250K-69.70%480K-57.29%592K
-accounts payable -43.84%237K-43.84%237K18.40%296K-9.79%433K-20.27%472K11.05%422K11.05%422K-74.23%250K-69.70%480K-57.29%592K
Current accrued expenses 17.38%5.11M17.38%5.11M33.25%4.57M-8.01%3.22M-3.31%2.77M-7.77%4.36M-7.77%4.36M-22.86%3.43M-7.81%3.5M-19.53%2.87M
Current debt and capital lease obligation 11.22%10.46M11.22%10.46M57.62%10.4M149.95%10.35M495.32%10.29M1,927.16%9.41M1,927.16%9.41M1,360.18%6.6M840.91%4.14M303.03%1.73M
-Current debt 11.27%9.9M11.27%9.9M61.49%9.85M168.59%9.81M679.49%9.77M--8.89M--8.89M--6.1M--3.65M--1.25M
-Current capital lease obligation 10.33%566K10.33%566K10.40%552K10.45%539K10.50%526K10.56%513K10.56%513K10.62%500K10.91%488K10.96%476K
Other current liabilities --21.72M--21.72M--------------------54.84%48K-23.81%48K-48.94%48K
Current liabilities 164.59%37.53M164.59%37.53M47.85%15.27M71.46%14M158.54%13.54M152.61%14.18M152.61%14.18M75.09%10.33M38.87%8.16M-4.31%5.24M
Non current liabilities
Long term debt and capital lease obligation -77.46%3.01M-77.46%3.01M-65.25%5.62M-55.94%8.21M-48.76%10.79M-40.20%13.36M-40.20%13.36M-27.67%16.17M-16.62%18.64M-5.83%21.06M
-Long term debt -78.98%2.6M-78.98%2.6M-66.38%5.07M-56.82%7.52M-49.46%9.96M-40.61%12.38M-40.61%12.38M-27.40%15.06M-15.64%17.4M-4.03%19.7M
-Long term capital lease obligation -58.17%407K-58.17%407K-49.86%555K-43.57%698K-38.59%837K-34.52%973K-34.52%973K-31.16%1.11M-28.29%1.24M-25.84%1.36M
Non current deferred liabilities ------------------------------108K--120K--132K
Derivative product liabilities --0--03,568.82%15.89M1,305.13%14.25M-21.50%909K-51.33%916K-51.33%916K-90.64%433K-79.70%1.01M-88.38%1.16M
Total non current liabilities -78.91%3.01M-78.91%3.01M28.69%21.51M13.59%22.46M-47.65%11.7M-41.42%14.27M-41.42%14.27M-38.06%16.71M-27.70%19.77M-30.86%22.35M
Total liabilities 42.46%40.54M42.46%40.54M36.00%36.77M30.50%36.46M-8.51%25.24M-5.07%28.46M-5.07%28.46M-17.76%27.04M-15.93%27.94M-27.02%27.59M
Shareholders'equity
Share capital 61.72%469K61.72%469K11.03%322K4.48%303K0.69%292K0.00%290K0.00%290K0.00%290K0.00%290K1.05%290K
-common stock 61.72%469K61.72%469K11.03%322K4.48%303K0.69%292K0.00%290K0.00%290K0.00%290K0.00%290K1.05%290K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -40.27%-192.21M-40.27%-192.21M-41.45%-178.13M-42.54%-167.49M-34.63%-145.25M-38.29%-137.03M-38.29%-137.03M-33.96%-125.93M-37.72%-117.5M-32.91%-107.88M
Paid-in capital 72.42%258.51M72.42%258.51M9.31%163M6.22%157.66M2.50%151.38M2.02%149.93M2.02%149.93M1.93%149.11M1.98%148.43M2.11%147.69M
Less: Treasury stock 0.00%448K0.00%448K0.00%448K0.00%448K0.00%448K0.00%448K0.00%448K0.00%448K0.00%448K--448K
Total stockholders'equity 420.42%66.33M420.42%66.33M-166.27%-15.26M-132.41%-9.97M-84.92%5.98M-73.29%12.75M-73.29%12.75M-55.83%23.02M-48.78%30.77M-37.81%39.65M
Total equity 420.42%66.33M420.42%66.33M-166.27%-15.26M-132.41%-9.97M-84.92%5.98M-73.29%12.75M-73.29%12.75M-55.83%23.02M-48.78%30.77M-37.81%39.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.96%
Sample Name
Sample Code
 +24.59%
Sample Name
Sample Code
 +20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 268.460
Sample Name
Sample Code
 382.190
Sample Name
Sample Code
 158.880
4
Meta Platforms
META
586.000
5
NVIDIA
NVDA
110.150
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 13.320
Sample Name
Sample Code
 7.560
Sample Name
Sample Code
 6.640
4
Cipher Mining
CIFR
2.460
5
Hive Blockchain
HIVE
1.540
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -